{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:21:28Z","timestamp":1794864088206,"version":"4.9.1"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Emerging evidence suggests that dysbiosis of the gut microbiota is associated with the pathogenesis of Parkinson\u2019s disease (PD), a prevalent neurodegenerative disorder. The microbiota\u2013gut\u2013brain axis plays a crucial role in the development and progression of PD, and numerous studies have demonstrated the potential therapeutic benefits of modulations in the intestinal microbiota. This review provides insights into the characterization of the gut microbiota in patients with PD and highlights associations with clinical symptoms and underlying mechanisms. The discussion underscores the increased influence of the gut microbiota in the pathogenesis of PD. While the relationship is not fully elucidated, existing research demonstrates a strong correlation between changes in the composition of gut microbiota and disease development, and further investigation is warranted to explain the specific underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003318","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:03:57Z","timestamp":1730865837000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["Gut microbiota and Parkinson\u2019s disease"],"prefix":"10.1097","volume":"138","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenish Sirajbhai","family":"Salewala","sequence":"additional","affiliation":[{"name":"International School, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiya","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houzhen","family":"Tuo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"R1-20250519","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"R2-20250519","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/mja17.00993","article-title":"Non-motor Parkinson disease: New concepts and personalised management","volume":"208","author":"Titova","year":"2018","journal-title":"Med J Aust"},{"key":"R3-20250519","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"R4-20250519","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2174\/1570159X19666210517115706","article-title":"Pharmacological and non-pharmacological treatments of sleep disorders in Parkinson\u2019s disease","volume":"19","author":"Taximaimaiti","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"R5-20250519","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: A dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R6-20250519","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1111\/ene.15671","article-title":"Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis","volume":"30","author":"Kleine Bardenhorst","year":"2023","journal-title":"Eur J Neurol"},{"key":"R7-20250519","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/CM9.0000000000002212","article-title":"Gut microbiota: a new insight into neurological diseases","volume":"136","author":"Liu","year":"2023","journal-title":"Chin Med J"},{"key":"R8-20250519","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41522-022-00367-z","article-title":"Inflammatory microbes and genes as potential biomarkers of Parkinson\u2019s disease","volume":"8","author":"Nie","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"key":"R9-20250519","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin Nutr"},{"key":"R10-20250519","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov Disord"},{"key":"R11-20250519","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: Evidence for overabundance of opportunistic pathogens","volume":"6","author":"Wallen","year":"2020","journal-title":"NPJ Parkinsons Dis"},{"key":"R12-20250519","doi-asserted-by":"crossref","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","article-title":"The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis","volume":"13","author":"Shen","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"R13-20250519","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/cns.13916","article-title":"New hope for Parkinson\u2019s disease treatment: Targeting gut microbiota","volume":"28","author":"Fan","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"R14-20250519","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov Disord"},{"key":"R15-20250519","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41392-020-00456-5","article-title":"Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R16-20250519","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"R17-20250519","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12398","article-title":"Meta-analysis: Association of Helicobacter pylori infection with Parkinson\u2019s diseases","volume":"22","author":"Shen","year":"2017","journal-title":"Helicobacter"},{"key":"R18-20250519","first-page":"CD008453","article-title":"Helicobacter pylori eradication for Parkinson\u2019s disease","volume":"9","author":"Rees","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20250519","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/mds.28248","article-title":"Helicobacter pylori eradication in Parkinson\u2019s disease: A randomized placebo-controlled trial","volume":"35","author":"Tan","year":"2020","journal-title":"Mov Disord"},{"key":"R20-20250519","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord"},{"key":"R21-20250519","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov Disord"},{"key":"R22-20250519","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12866-023-02933-7","article-title":"Study of the gut microbiome in Egyptian patients with Parkinson\u2019s disease","volume":"23","author":"Mehanna","year":"2023","journal-title":"BMC Microbiol"},{"key":"R23-20250519","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.08.022","article-title":"Probiotics for constipation and gut microbiota in Parkinson\u2019s disease","volume":"103","author":"Du","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"key":"R24-20250519","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","article-title":"Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates","volume":"65","author":"Vandeputte","year":"2016","journal-title":"Gut"},{"key":"R25-20250519","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JPD-202297","article-title":"Does gut microbiota influence the course of Parkinson\u2019s disease? A 3-year prospective exploratory study in de novo patients","volume":"11","author":"Cilia","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"R26-20250519","doi-asserted-by":"crossref","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson\u2019s disease is associated with gut dysbiosis: Two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS One"},{"key":"R27-20250519","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41531-022-00327-6","article-title":"Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease","volume":"8","author":"Sun","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"R28-20250519","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov Disord"},{"key":"R29-20250519","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fneur.2018.00767","article-title":"Neuroimaging of sleep disturbances in movement disorders","volume":"9","author":"Yousaf","year":"2018","journal-title":"Front Neurol"},{"key":"R30-20250519","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: A 16-year update on a previously reported series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"key":"R31-20250519","doi-asserted-by":"crossref","first-page":"357","DOI":"10.14336\/AD.2023.0518","article-title":"Relationships between rapid eye movement sleep behavior disorder and Parkinson\u2019s disease: Indication from gut microbiota alterations","volume":"15","author":"Zhang","year":"2024","journal-title":"Aging Dis"},{"key":"R32-20250519","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1038\/s41467-023-38248-4","article-title":"Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"R33-20250519","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: A Danish nationwide cohort study 1977-2014","volume":"68","author":"Villumsen","year":"2019","journal-title":"Gut"},{"key":"R34-20250519","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol"},{"key":"R35-20250519","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"R36-20250519","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: A translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"key":"R37-20250519","doi-asserted-by":"crossref","first-page":"104821","DOI":"10.1016\/j.nbd.2020.104821","article-title":"Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration","volume":"139","author":"Pellegrini","year":"2020","journal-title":"Neurobiol Dis"},{"key":"R38-20250519","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med"},{"key":"R39-20250519","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","article-title":"Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease","volume":"3","author":"Clairembault","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"R40-20250519","doi-asserted-by":"crossref","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in Parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol Dis"},{"key":"R41-20250519","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat Neurosci"},{"key":"R42-20250519","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"R43-20250519","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/08977150151071035","article-title":"Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury","volume":"18","author":"Lau","year":"2001","journal-title":"J Neurotrauma"},{"key":"R44-20250519","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: Is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"R45-20250519","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4\u00a0signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"R46-20250519","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"R47-20250519","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.4049\/jimmunol.1700105","article-title":"Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of claudin-2","volume":"199","author":"Zheng","year":"2017","journal-title":"J Immunol"},{"key":"R48-20250519","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","article-title":"Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice","volume":"145","author":"Kim","year":"2013","journal-title":"Gastroenterology"},{"key":"R49-20250519","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"R50-20250519","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/metabo11010029","article-title":"Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson\u2019s disease","volume":"11","author":"Li","year":"2021","journal-title":"Metabolites"},{"key":"R51-20250519","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12864-019-6186-z","article-title":"Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans","volume":"20","author":"Wallner","year":"2019","journal-title":"BMC Genomics"},{"key":"R52-20250519","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2018.01.025","article-title":"Potential biomarkers of Parkinson\u2019s disease revealed by plasma metabolic profiling","volume":"1081-1082","author":"Zhao","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R53-20250519","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bbadis.2017.06.004","article-title":"Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson\u2019s disease","volume":"1863","author":"Rosa","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R54-20250519","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12035-012-8295-4","article-title":"Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson\u2019s disease","volume":"46","author":"Castro-Caldas","year":"2012","journal-title":"Mol Neurobiol"},{"key":"R55-20250519","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1007\/s12035-018-1062-4","article-title":"Tauroursodeoxycholic acid improves motor symptoms in a mouse model of Parkinson\u2019s disease","volume":"55","author":"Rosa","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R56-20250519","doi-asserted-by":"crossref","first-page":"e4985","DOI":"10.1002\/bmc.4985","article-title":"Rapid simultaneous determination of gut microbial phenylalanine, tyrosine, and tryptophan metabolites in rat serum, urine, and faeces using LC-MS\/MS and its application to a type 2\u00a0diabetes mellitus study","volume":"35","author":"Zou","year":"2021","journal-title":"Biomed Chromatogr"},{"key":"R57-20250519","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.28202","article-title":"Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson\u2019s disease","volume":"35","author":"Heilman","year":"2020","journal-title":"Mov Disord"},{"key":"R58-20250519","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.chom.2014.09.001","article-title":"Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine","volume":"16","author":"Williams","year":"2014","journal-title":"Cell Host Microbe"},{"key":"R59-20250519","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0306-4522(96)00655-0","article-title":"Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid","volume":"78","author":"Miranda","year":"1997","journal-title":"Neuroscience"},{"key":"R60-20250519","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R61-20250519","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex","volume":"108","author":"Beal","year":"1992","journal-title":"J Neurol Sci"},{"key":"R62-20250519","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ntt.2010.10.002","article-title":"Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy","volume":"33","author":"Silva-Adaya","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"R63-20250519","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41531-022-00312-z","article-title":"Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson\u2019s disease","volume":"8","author":"Zhang","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"R64-20250519","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbi.2022.09.009","article-title":"Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson\u2019s disease: An animal study","volume":"106","author":"Yan","year":"2022","journal-title":"Brain Behav Immun"},{"key":"R65-20250519","doi-asserted-by":"crossref","first-page":"111762","DOI":"10.1016\/j.nut.2022.111762","article-title":"Potential roles of branched-chain amino acids in neurodegeneration","volume":"103\u2013104","author":"Yoo","year":"2022","journal-title":"Nutrition"},{"key":"R66-20250519","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"R67-20250519","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol"},{"key":"R68-20250519","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"R69-20250519","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"R70-20250519","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"R71-20250519","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.7150\/ijbs.42257","article-title":"Parkinson\u2019s disease: A comprehensive analysis of fungi and bacteria in brain tissue","volume":"16","author":"Pisa","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R72-20250519","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gendis.2019.01.004","article-title":"Impact of gene mutation in the development of Parkinson\u2019s disease","volume":"6","author":"Selvaraj","year":"2019","journal-title":"Genes Dis"},{"key":"R73-20250519","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41531-021-00218-2","article-title":"Exploring human-genome gut-microbiome interaction in Parkinson\u2019s disease","volume":"7","author":"Wallen","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"R74-20250519","doi-asserted-by":"crossref","first-page":"2276296","DOI":"10.1080\/19490976.2023.2276296","article-title":"Escherichia coli triggers \u03b1-synuclein pathology in the LRRK2 transgenic mouse model of PD","volume":"15","author":"Liang","year":"2023","journal-title":"Gut Microbes"},{"key":"R75-20250519","doi-asserted-by":"crossref","first-page":"e2443","DOI":"10.1212\/WNL.0000000000201204","article-title":"Association between microbial tyrosine decarboxylase gene and levodopa responsiveness in patients with Parkinson disease","volume":"99","author":"Zhang","year":"2022","journal-title":"Neurology"},{"key":"R76-20250519","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1(-\/-) mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"R77-20250519","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijfoodmicro.2009.01.011","article-title":"Impact of coffee consumption on the gut microbiota: A human volunteer study","volume":"130","author":"Jaquet","year":"2009","journal-title":"Int J Food Microbiol"},{"key":"R78-20250519","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3390\/nu12061860","article-title":"The effect of caffeine on the risk and progression of Parkinson\u2019s disease: A meta-analysis","volume":"12","author":"Hong","year":"2020","journal-title":"Nutrients"},{"key":"R79-20250519","doi-asserted-by":"crossref","first-page":"794640","DOI":"10.3389\/fneur.2021.794640","article-title":"Mediterranean diet adherence in people with Parkinson\u2019s disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study","volume":"12","author":"Rusch","year":"2021","journal-title":"Front Neurol"},{"key":"R80-20250519","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"key":"R81-20250519","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"key":"R82-20250519","doi-asserted-by":"crossref","first-page":"e81453","DOI":"10.7554\/eLife.81453","article-title":"A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice","volume":"11","author":"Abdel-Haq","year":"2022","journal-title":"Elife"},{"key":"R83-20250519","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","article-title":"An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants","volume":"14","author":"Hall","year":"2023","journal-title":"Nat Commun"},{"key":"R84-20250519","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1039\/D3FO00728F","article-title":"Effect of Lacticaseibacillus paracasei\u00a0strain Shirota supplementation on clinical responses and gut microbiome in Parkinson\u2019s disease","volume":"14","author":"Yang","year":"2023","journal-title":"Food Funct"},{"key":"R85-20250519","doi-asserted-by":"crossref","first-page":"650053","DOI":"10.3389\/fnut.2021.650053","article-title":"The add-on effect of Lactobacillus plantarum PS128 in patients with Parkinson\u2019s disease: A pilot study","volume":"8","author":"Lu","year":"2021","journal-title":"Front Nutr"},{"key":"R86-20250519","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav Immun"},{"key":"R87-20250519","doi-asserted-by":"crossref","first-page":"e10505","DOI":"10.1002\/btm2.10505","article-title":"Neuroprotective effect of engineered Clostridium butyricum-pMTL007-GLP-1 on Parkinson\u2019s disease mice models via promoting mitophagy","volume":"8","author":"Wang","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"R88-20250519","doi-asserted-by":"crossref","first-page":"1022879","DOI":"10.3389\/fcimb.2022.1022879","article-title":"Probiotic Pediococcus pentosaceus ameliorates MPTP-induced oxidative stress via regulating the gut microbiota-gut-brain axis","volume":"12","author":"Pan","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R89-20250519","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","article-title":"Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson\u2019s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder","volume":"70","author":"Wang","year":"2022","journal-title":"J Agric Food Chem"},{"key":"R90-20250519","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.3390\/nu14224886","article-title":"Neurotrophic role of the next-generation probiotic strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson\u2019s disease via inhibiting ferroptosis","volume":"14","author":"Yue","year":"2022","journal-title":"Nutrients"},{"key":"R91-20250519","first-page":"1927","article-title":"Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85\u00a0diseases","volume":"135","author":"Wang","year":"2022","journal-title":"Chin Med J"},{"key":"R92-20250519","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: Gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav Immun"},{"key":"R93-20250519","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","article-title":"Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation","volume":"20","author":"Kuai","year":"2021","journal-title":"Microb Cell Fact"},{"key":"R94-20250519","doi-asserted-by":"crossref","first-page":"2284247","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: Clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut Microbes"},{"key":"R95-20250519","doi-asserted-by":"crossref","first-page":"102563","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): A double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"eClinicalMedicine"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T10:00:37Z","timestamp":1747648837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003318","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"2024-04-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}